NIPE Monitoring Values During Routine Pediatric Anesthesia (OMNIPED)

January 25, 2023 updated by: University Hospital, Lille

Parasympathetic Activity Evaluation by Newborn Infant Parasympathetic Evaluation (NIPE) Monitor (MDMSTM, Loos, France) During Routine General Anesthesia in Children

Description of the standard values and fluctuations of the new NIPE index during routine pediatric anesthesia. NIPE monitor connected to anesthesia monitor, displays an instantaneous value ranging from 0 to 100. NIPE values described at different time points during anesthesia: beginning of induction, intubation, extubation, skin incision, opioid administration, vasopressors or atropine administration, transfusion, volume expansion. In addition, NIPE values during hemodynamic events (heart rate or blood pressure increase greater than 20%) will be recorded.

Study Overview

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Lille, France, 59037
        • Hop Jeanne de Flandre Chu Lille

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Children in the pediatric surgical wardof:

  • Lille University hospital (Lille, France)
  • Armand Trousseau Hospital (Paris, France)

Description

Inclusion Criteria:

  • Surgery under general anesthesia
  • Absence of analgesic treatment in the 24 hours before the intervention

Exclusion Criteria:

  • Central or peripheral neuropathy
  • Non sinus arrythmia, pace maker
  • Cardiac surgery
  • Analgesic medication within 24 hours before surgery
  • Anti cholinergic or anti arrythmic chronic medication
  • Opposition of the legal tutor or of the child

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children
0-15 years old children undergoing surgery under general anesthesia
Non invasive monitor connected to standard anesthesia monitor (no part of the device in contact with the patient) during anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Variation of the instantaneous NIPE index after opioid administration
Time Frame: 5 minutes after opioid administration
5 minutes after opioid administration

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the area under the ROC curve of NIPE value
Time Frame: Baseline and 5 minutes before the first hemodynamic event.
the NIPE value is definied by the predictibility of a hemodynamic event : 20% increase in Baseline heart rate, blood pressure and NIPE values recorded just before skin incision
Baseline and 5 minutes before the first hemodynamic event.
Variation of the instantaneous NIPE index after skin incision
Time Frame: 5 minutes after skin incision
5 minutes after skin incision
Variation of the instantaneous NIPE index after insertion of airway control device
Time Frame: 5 minutes after insertion of airway control device
5 minutes after insertion of airway control device
Variation of the instantaneous NIPE index after removal of airway control device
Time Frame: 5 minutes after removal of airway control device
5 minutes after removal of airway control device
Variation of the instantaneous NIPE index after anesthetic induction
Time Frame: 5 minutes after anesthetic induction
5 minutes after anesthetic induction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Anne LAFFARGUE, MD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 23, 2020

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

June 4, 2020

First Submitted That Met QC Criteria

June 11, 2020

First Posted (Actual)

June 16, 2020

Study Record Updates

Last Update Posted (Estimate)

January 26, 2023

Last Update Submitted That Met QC Criteria

January 25, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019_31
  • 2020-A00059-30 (Other Identifier: ID-RCB number,ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on NIPE (Newborn Infant Parasympathetic Evaluation) monitoring

3
Subscribe